Literature DB >> 9392541

Combined castration and fractionated radiotherapy in an experimental prostatic adenocarcinoma.

T Granfors1, J E Damber, A Bergh, M Landström, P O Löfroth, A Widmark.   

Abstract

PURPOSE: The present study using the Dunning R3327-PAP rat prostatic adenocarcinoma model was designed to study the effect on tumor growth of castration prior to or after irradiation with 20-25 Gy as compared with either irradiation or castration alone. METHODS AND MATERIALS: Rats were bilaterally orchidectomized. During the irradiation procedure the nonanesthetized animals were held in a metallic frame with a strong cotton net and they were observed by means of a video camera. The suboptimal irradiation dose was given once daily with a 4-MeV linear accelerator, 4-5 Gy/fraction, during 5 consecutive days. Tumor volumes and rat weights were followed. At the end point of the study the animals were sacrificed and the tumors were morphometrically analyzed.
RESULTS: The combination of irradiation and castration delayed tumor regrowth better than irradiation alone with the same suboptimal dose. Castration before irradiation delayed tumor regrowth more efficiently than castration after irradiation. However, castration alone delayed tumor regrowth even more effectively than suboptimal irradiation doses combined with castration.
CONCLUSIONS: In combination with suboptimal irradiation neoadjuvant androgen deprivation was more inhibitory to rat prostatic adenocarcinoma regrowth than adjuvant androgen deprivation. Irradiation with suboptimal doses combined with castration may cause an earlier relapse to androgen-independent tumor growth than castration alone.

Entities:  

Mesh:

Year:  1997        PMID: 9392541     DOI: 10.1016/s0360-3016(97)00559-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer.

Authors:  Michael J Zelefsky; Victor E Reuter; Zvi Fuks; Peter Scardino; Alison Shippy
Journal:  J Urol       Date:  2008-03-04       Impact factor: 7.450

2.  Sequencing of Androgen-Deprivation Therapy With External-Beam Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled Trial.

Authors:  Shawn Malone; Soumyajit Roy; Libni Eapen; Choan E; Robert MacRae; Gad Perry; Julie Bowen; Rajiv Samant; Scott Morgan; Julia Craig; Kyle Malone; Scott Grimes
Journal:  J Clin Oncol       Date:  2019-12-12       Impact factor: 44.544

3.  Analysis of prognostic factors in localized high-risk prostate cancer patients treated with HDR brachytherapy, hypofractionated 3D-CRT and neoadjuvant/adjuvant androgen deprivation therapy (trimodality therapy).

Authors:  Manabu Aoki; Kenta Miki; Masahito Kido; Hiroshi Sasaki; Wataru Nakamura; Yoshikazu Kijima; Masao Kobayashi; Shin Egawa; Chihiro Kanehira
Journal:  J Radiat Res       Date:  2013-12-17       Impact factor: 2.724

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.